Sana Biotechnology to Showcase Innovations at Investor Events
Sana Biotechnology, Inc. (NASDAQ: SANA) is poised to present its vision for engineered cell therapies at upcoming investor conferences. The company focuses on transforming patient care through innovative genetic treatments and engineered cells.
Details of the Presentations
Sana's presentations will take place during two prominent investor conferences in December. Steve Harr, the President and CEO, will lead the discussions, providing insights into the company's current developments and future strategies.
Citi’s 2025 Global Healthcare Conference
The first conference that Sana will attend is Citi’s 2025 Global Healthcare Conference, scheduled for December 2, 2025, at 2:30 p.m. ET. Here, Sana will give an overview of its strategic initiatives and growth prospects.
8th Annual Evercore Healthcare Conference
Following the Citi conference, Sana will present at the 8th Annual Evercore Healthcare Conference on December 3, 2025, at 2:35 p.m. ET. This event represents a valuable opportunity for Sana to connect with investors and highlight its key projects.
Accessing the Webcasts
Investors and interested parties can access the live webcasts via the Investor Relations section on Sana's official website. Additionally, recordings of the sessions will be available for 30 days after the events, allowing more people to engage with the content.
About Sana Biotechnology
Sana Biotechnology is committed to advancing cell-based therapies aimed at repairing and replacing damaged cells in patients. Its mission embodies a vision where patients regain control over their health through groundbreaking scientific advancements. The team at Sana works passionately to ensure these therapeutic options are accessible to those in need.
With operations in regions including Seattle, Cambridge, and South San Francisco, Sana is strategically positioned to make significant strides in the biotech industry. The company focuses on developing innovative solutions that could redefine treatment options for various diseases.
Contact Information
For any media or investor inquiries, please reach out to:
Nicole Keith
Email: investor.relations@sana.com
Email: media@sana.com
Frequently Asked Questions
What is the focus of Sana Biotechnology?
Sana Biotechnology focuses on developing engineered cells as therapeutics to transform patient treatment options for various diseases.
Who will be presenting at the investor conferences?
Steve Harr, the President and CEO of Sana Biotechnology, will lead the presentations, sharing vital insights about the company's direction.
When are the upcoming investor presentations?
The presentations will occur on December 2 and December 3, 2025, at the Citi and Evercore Healthcare Conferences, respectively.
How can investors access the webcasts of the presentations?
The webcasts will be available on Sana’s Investor Relations page, with replays accessible for 30 days following the events.
Where are Sana Biotechnology's operational locations?
Sana has operations in Seattle, Cambridge, and South San Francisco, positioning itself to facilitate advancements in cell therapy across various regions.